Clinical Trials Browser

Phase 1/2 × defactinib × Gynecologic × Clear all

NCT03287271 2024-08-12

ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK

Phase 1/2 Recruiting

Neoplasms, Ovarian Neoplasms